Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Surgical Endoscopy
|
April 9, 2017
Comparison of laparoscopic liver resection for lesions located in anterolateral and posterosuperior segments: a meta-analysis
Benbo Zheng, Rongce Zhao, Xiaodong Li, et al.
Frontiers in Immunology
|
May 27, 2024
Efficacy and safety of lenvatinib plus durvalumab combined with hepatic arterial infusion chemotherapy for unresectable intrahepatic cholangiocarcinoma
Rongce Zhao, Jing Zhou, Zhaoxia Miao, et al.
Acta Biochimica Et Biophysica Sinica
|
December 13, 2019
CAF-induced placental growth factor facilitates neoangiogenesis in hepatocellular carcinoma
Zhongjian Liu, Mingmei Chen, Rongce Zhao, et al.
World Journal of Surgery
|
September 30, 2018
Hepatic Pedicle Occlusion with the Pringle Maneuver During Difficult Laparoscopic Cholecystectomy Reduces the Conversion Rate
Rongce Zhao, Fei Liu, Chenyang Jia, et al.
American Journal of Cancer Research
|
November 18, 2024
Hepatic arterial infusion chemotherapy in combination with lenvatinib and durvalumab versus standard first-line treatment gemcitabine and cisplatin plus durvalumab in advanced intrahepatic cholangiocarcinoma
Rongce Zhao, Jing Zhou, Xinhao Xiong, et al.
Journal of Hepatocellular Carcinoma
|
November 4, 2024
FOLFOX-Based Hepatic Arterial Infusion Chemotherapy with Sequential Drug-Eluting Bead Transarterial Chemoembolization for Unresectable Large Hepatocellular Carcinoma: A Single-Center Retrospective Cohort Study
Rongce Zhao, Jing Zhou, Zehao Zheng, et al.
Medicine
|
March 23, 2017
The prognostic role of BORIS and SOCS3 in human hepatocellular carcinoma
Rongce Zhao, Kefei Chen, Jing Zhou, et al.
Medicine
|
July 12, 2016
Economic evaluation study (CHEER-compliant): Cost-effectiveness analysis of RAS screening for treatment of metastatic colorectal cancer based on the CALGB 80405 trial
Jing Zhou, Rongce Zhao, Feng Wen, et al.
European Journal of Medical Research
|
September 9, 2023
Development of nomograms to predict recurrence after conversion hepatectomy for hepatocellular carcinoma previously treated with transarterial interventional therapy
Min Deng, Rongce Zhao, Renguo Guan, et al.
Molecular Medicine (Cambridge, Mass.)
|
February 6, 2022
The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma
Min Deng, Shiquan Sun, Rongce Zhao, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Surgical Endoscopy
|
April 9, 2017
Comparison of laparoscopic liver resection for lesions located in anterolateral and posterosuperior segments: a meta-analysis
Benbo Zheng, Rongce Zhao, Xiaodong Li, et al.
Frontiers in Immunology
|
May 27, 2024
Efficacy and safety of lenvatinib plus durvalumab combined with hepatic arterial infusion chemotherapy for unresectable intrahepatic cholangiocarcinoma
Rongce Zhao, Jing Zhou, Zhaoxia Miao, et al.
Acta Biochimica Et Biophysica Sinica
|
December 13, 2019
CAF-induced placental growth factor facilitates neoangiogenesis in hepatocellular carcinoma
Zhongjian Liu, Mingmei Chen, Rongce Zhao, et al.
World Journal of Surgery
|
September 30, 2018
Hepatic Pedicle Occlusion with the Pringle Maneuver During Difficult Laparoscopic Cholecystectomy Reduces the Conversion Rate
Rongce Zhao, Fei Liu, Chenyang Jia, et al.
American Journal of Cancer Research
|
November 18, 2024
Hepatic arterial infusion chemotherapy in combination with lenvatinib and durvalumab versus standard first-line treatment gemcitabine and cisplatin plus durvalumab in advanced intrahepatic cholangiocarcinoma
Rongce Zhao, Jing Zhou, Xinhao Xiong, et al.
Journal of Hepatocellular Carcinoma
|
November 4, 2024
FOLFOX-Based Hepatic Arterial Infusion Chemotherapy with Sequential Drug-Eluting Bead Transarterial Chemoembolization for Unresectable Large Hepatocellular Carcinoma: A Single-Center Retrospective Cohort Study
Rongce Zhao, Jing Zhou, Zehao Zheng, et al.
Medicine
|
March 23, 2017
The prognostic role of BORIS and SOCS3 in human hepatocellular carcinoma
Rongce Zhao, Kefei Chen, Jing Zhou, et al.
Medicine
|
July 12, 2016
Economic evaluation study (CHEER-compliant): Cost-effectiveness analysis of RAS screening for treatment of metastatic colorectal cancer based on the CALGB 80405 trial
Jing Zhou, Rongce Zhao, Feng Wen, et al.
European Journal of Medical Research
|
September 9, 2023
Development of nomograms to predict recurrence after conversion hepatectomy for hepatocellular carcinoma previously treated with transarterial interventional therapy
Min Deng, Rongce Zhao, Renguo Guan, et al.
Molecular Medicine (Cambridge, Mass.)
|
February 6, 2022
The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma
Min Deng, Shiquan Sun, Rongce Zhao, et al.
Page
of 3